Welcome to LookChem.com Sign In|Join Free
  • or
2-(Butylamino)-2-phenylcyclohexanone is a chemical compound with the molecular formula C17H25NO. It is a derivative of cyclohexanone, featuring a butylamino group attached to the 2-position and a phenyl group at the same position. 2-(butylamino)-2-phenylcyclohexanone is known for its potential applications in the synthesis of various pharmaceuticals and agrochemicals due to its unique structure. It is an oily liquid at room temperature and is soluble in organic solvents. The compound is synthesized through a series of chemical reactions, often involving the condensation of cyclohexanone with the appropriate amine and phenyl group. It is important to handle 2-(butylamino)-2-phenylcyclohexanone with care due to its potential reactivity and the need for proper safety measures during its production and use.

7015-33-0

Post Buying Request

7015-33-0 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

7015-33-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 7015-33-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 7,0,1 and 5 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 7015-33:
(6*7)+(5*0)+(4*1)+(3*5)+(2*3)+(1*3)=70
70 % 10 = 0
So 7015-33-0 is a valid CAS Registry Number.

7015-33-0Downstream Products

7015-33-0Relevant academic research and scientific papers

Improved methods for thermal rearrangement of alicyclic α-hydroxyimines to α-aminoketones: Synthesis of ketamine analogues as antisepsis candidates

Elhawi, Hagit,Eini, Hadar,Douvdevani, Amos,Byk, Gerardo

, p. 6784 - 6807 (2012/09/07)

Ketamine is an analgesic/anesthetic drug, which, in combination with other drugs, has been used as anesthetic for over 40 years. Ketamine induces its analgesic activities by blocking the N-methyl-D-aspartate (NMDA) receptor in the central nervous system (CNS). We have reported that low doses of ketamine administrated to patients before incision significantly reduced post-operative inflammation as reflected by reduced interleukin-6 (IL-6) sera-levels. Our data demonstrated in a rat model of Gram-negative bacterial-sepsis that if we inject a low dose of ketamine following bacterial inoculation we reduce mortality from approximately 75% to 25%. Similar to what we have observed in operated patients, the levels of TNF-α and IL-6 in ketamine-treated rats were significantly lower than in septic animals not treated with ketamine. On the base of these results, we have designed and synthesized series of new analogues of ketamine applying a thermal rearrangement of alicyclic α-hydroxyimines to α-aminoketones in parallel arrays. One of the analogues (compound 6e) displayed high activity in down-regulating the levels of IL-6 and TNF-α in vivo as compared to ketamine.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 7015-33-0